# US 2025/0002846 A1 · Method for construction of inner ear organoid

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0002846 A1
- Document ID: US20250002846A1
- Status: Published application
- Kind: A1
- Application number: 18/711,270
- Filed: 2022-12-23
- Published: 2025-01-02
- Earliest claimed: 2022-01-12
- Assignees: Industry Foundation of Chonnam National University; Ajou University Industry-Academic Cooperation Foundation
- Applicants: Industry Foundation of Chonnam National University; Ajou University Industry-Academic Cooperation Foundation
- Inventors: JANG HO KIM; YUN HOON CHOUNG; SUN HO PARK; YEON JU KIM
- Web page: https://patentgrep.com/patent/US20250002846A1

## CPC

- C12N 5/062: {Sensory transducers, e.g. photoreceptors; Sensory neurons, e.g. for hearing, taste, smell, pH, touch, temperature, pain}
- C12M 1/32: multiple field or continuous type
- C12M 23/12: {Well or multiwell plates (C12M25/04 takes precedence)}
- C12N 5/06: {Animal cells or tissues; Human cells or tissues (preservation of excised living parts A01N1/10)}
- C12N 2501/11: Epidermal growth factor [EGF]
- C12N 2501/115: Basic fibroblast growth factor (bFGF, FGF-2)
- C12N 2501/119: Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
- C12N 2501/13: Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins
- C12N 2501/15: Transforming growth factor beta (TGF-β)
- C12N 2501/155: Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
- C12N 2501/727: Kinases (EC 2.7.)
- C12N 2506/02: from embryonic cells
- C12N 2506/45: from artificially induced pluripotent stem cells
- C12N 2513/00: 3D culture
- C12N 2533/54: Collagen; Gelatin
- C12N 2533/90: Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12M: APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; {APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS}

## Abstract

In a method for producing an inner ear organoid, stem cells and a culture medium are treated on a microwell plate whose an inner circumferential surface has a curved surface inclined downward, the stem cells are seeded in each microwell, and the stem cells seeded in each microwell are cultured. Using the method, cell aggregates for production of inner ear organoids may be easily formed, and uniform and mature inner ear organoids may be produced using the specific initial cell number control method and growth factor treatment method of the present invention, and may be used for inner ear disease modeling and drug screening.

## Claims

### Claim 1

A method for producing an inner ear organoid, comprising:
treating stem cells and a culture medium on a microwell plate whose an inner circumferential surface has a curved surface inclined downward, and seeding the stem cells in each microwell; and
culturing the stem cells seeded in each microwell.

### Claim 2 (depends on 1)

The method for producing an inner ear organoid according to claim 1, wherein the microwell has a width of 100 to 1000 μm.

### Claim 3 (depends on 1)

The method for producing an inner ear organoid according to claim 1, wherein the inner circumferential surface of the microwell has a first curved surface inclined downward and a second curved surface inclined downward which is connected to the first curved surface.

### Claim 4 (depends on 1)

The method for producing an inner ear organoid according to claim 1, wherein the microwell has a width of 450 to 550 μm, and 1.5×103 to 4.5×103 stem cells are seeded in each microwell.

### Claim 5 (depends on 1)

The method for producing an inner ear organoid according to claim 1, further comprising: treating Matrigel on day 1 of culture of the stem cells; and treating bone morphogenetic protein 4 (BMP4) and SB-431542 on day 3 of culture.

### Claim 6 (depends on 1)

The method for producing an inner ear organoid according to claim 1, further comprising: differentiating the stem cells into non-neural ectoderm; and isolating the non-neural ectoderm from the microwells.

### Claim 7 (depends on 6)

The method for producing an inner car organoid according to claim 6, further comprising: treating the isolated non-neural ectoderm with fibroblast growth factor 2 (FGF2) and LDN193189.
